Tonix Pharmaceuticals Holding Corp (TNXP)

Oct 12, 2026

Tonix Pharmaceuticals Q3 2026 Earnings Date and Estimates - MarketBeat

Oct 12, 2026

Oct 05, 2026

Tonix Pharmaceuticals Gains On Update for TNX-102 SL - Baystreet.ca

Oct 05, 2026

Oct 05, 2026

Tonix Pharmaceuticals Holding (NasdaqGS:TNXP) Stock Forecast & Analyst Predictions - Simply Wall Street

Oct 05, 2026

Oct 04, 2026

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Rating Raised to "Hold" at Wall Street Zen - MarketBeat

Oct 04, 2026

Oct 02, 2026

Tonix Pharmaceuticals (TNXP) 10K Form and Latest SEC Filings 2026 - MarketBeat

Oct 02, 2026

Sep 30, 2026

Why Is Tonix Pharmaceuticals (NASDAQ:TNXP) Moving Into Focus? - Kalkine Media

Sep 30, 2026

Sep 29, 2026

Tonix Pharmaceuticals Holding (TNXP) Stock Price, News & Analysis - Stock Titan

Sep 29, 2026

Sep 26, 2026

Tonix Pharmaceuticals (NASDAQ:TNXP) Downgraded by Wall Street Zen to Sell - MarketBeat

Sep 26, 2026

Sep 24, 2026

Tonix Pharmaceuticals (TNXP) Short Interest & Short Float | Updated Sep 2026 - MarketBeat

Sep 24, 2026

Sep 22, 2026

Tonix expands Medicare coverage for fibromyalgia drug TONMYA - Investing.com

Sep 22, 2026

Sep 22, 2026

Tonix Pharmaceuticals Adds ~21M Medicare Lives for TONMYA, Total Coverage Now ~166M U.S. Lives - TradingView

Sep 22, 2026

Sep 22, 2026

Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA® - Yahoo Finance

Sep 22, 2026

Sep 22, 2026

Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA® - GlobeNewswire

Sep 22, 2026

Sep 22, 2026

Raymond James reiterates Strong Buy on Tonix Pharma stock at $27 - Investing.com

Sep 22, 2026

Sep 11, 2026

Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears - marketbeat.com

Sep 11, 2026

Sep 11, 2026

Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears - MarketBeat

Sep 11, 2026

Sep 11, 2026

Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears - Yahoo Finance

Sep 11, 2026

Sep 11, 2026

Could Market Volatility Test Tonix Pharmaceuticals (NASDAQ:TNXP)? - Kalkine Media

Sep 11, 2026

Sep 10, 2026

Tonix Pharmaceuticals at Cantor conference: launch gains and pipeline push By Investing.com - Investing.com Canada

Sep 10, 2026

Sep 10, 2026

Tonix Pharmaceuticals at Cantor conference: launch gains and pipeline push By Investing.com - Investing.com India

Sep 10, 2026

Sep 10, 2026

Tonix Pharmaceuticals at Cantor conference: launch gains and pipeline push By Investing.com - Investing.com UK

Sep 10, 2026

Sep 10, 2026

Q3 EPS Estimate for Tonix Pharmaceuticals Raised by Analyst - marketbeat.com

Sep 10, 2026

Sep 09, 2026

What macro factors could move Tonix Pharmaceuticals (NASDAQ:TNXP) shares this week? - Kalkine Media

Sep 09, 2026

Sep 09, 2026

Tonix Pharma Appoints New Chief Commercial Officer - The Globe and Mail

Sep 09, 2026

Sep 09, 2026

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Sep 09, 2026

Sep 08, 2026

Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer - Minichart

Sep 08, 2026

Sep 08, 2026

Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer - citybiz

Sep 08, 2026

Sep 08, 2026

TNXP Looks 393.2% Overvalued on GF Value™ - GuruFocus

Sep 08, 2026

Sep 08, 2026

Tonix Pharmaceuticals Holding Corp. Announces Appointment of Thomas Englese to Chief Commercial Officer, Effective September 8, 2026 - marketscreener.com

Sep 08, 2026

Sep 08, 2026

Why is Tonix Pharmaceuticals (NASDAQ:TNXP) stock in focus as Wall Street reopens today? - Kalkine Media

Sep 08, 2026

Sep 08, 2026

Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer - Yahoo Finance

Sep 08, 2026

Sep 06, 2026

Price-Driven Insight from (TNXP) for Rule-Based Strategy - Stock Traders Daily

Sep 06, 2026

Sep 02, 2026

TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26 - finance.yahoo.com

Sep 02, 2026

Sep 02, 2026

Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference - GlobeNewswire

Sep 02, 2026

Sep 02, 2026

Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference - Yahoo Finance

Sep 02, 2026

Sep 02, 2026

Tonix CEO will speak at a healthcare conference Sept. 10 - Stock Titan

Sep 02, 2026

Aug 31, 2026

Tonix Pharmaceuticals CEO Seth Lederman buys $27,580 in stock By Investing.com - Investing.com South Africa

Aug 31, 2026

Aug 31, 2026

Tonix Pharmaceuticals CEO Seth Lederman buys $27,580 in stock By Investing.com - Investing.com India

Aug 31, 2026

Aug 31, 2026

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Buys $27,580.00 in Stock - MarketBeat

Aug 31, 2026

Aug 31, 2026

Tonix Pharmaceuticals CEO Seth Lederman buys $27,580 in stock - Investing.com

Aug 31, 2026

Aug 31, 2026

Tonix Pharmaceuticals CEO Seth Lederman buys $27,580 in stock By Investing.com - Investing.com UK

Aug 31, 2026

Aug 31, 2026

Tonix Pharma (NASDAQ: TNXP) CEO adds 2,000 shares in IRA - Stock Titan

Aug 31, 2026

Aug 29, 2026

Tonix Pharmaceuticals (NASDAQ:TNXP) Rating Increased to Hold at Wall Street Zen - marketbeat.com

Aug 29, 2026

Aug 24, 2026

Tonix Pharmaceuticals director bagger buys $12,600 in stock By Investing.com - Investing.com Canada

Aug 24, 2026

Aug 24, 2026

Tonix Pharmaceuticals director bagger buys $12,600 in stock By Investing.com - Investing.com Nigeria

Aug 24, 2026

Aug 24, 2026

Tonix Pharmaceuticals director bagger buys $12,600 in stock By Investing.com - Investing.com UK

Aug 24, 2026

Aug 24, 2026

Tonix Pharmaceuticals director bagger buys $12,600 in stock - investing.com

Aug 24, 2026

Aug 24, 2026

Tonix Pharmaceuticals (TNXP) director buys 1,000 company shares - Stock Titan

Aug 24, 2026

Aug 22, 2026

Tonix (TNXP) Market: Adds 1.29% to Close at $12.55; the Near-Term Reference Band Stretches From $11.92 to $13.18 in the Latest ReadingPositive Gamma - siam.in

Aug 22, 2026

Aug 19, 2026

Tonix Pharma Names CEO Seth Lederman Interim CMO - The Globe and Mail

Aug 19, 2026